相关实验视频

Updated: Jun 16, 2026

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion
07:30

Assessing Insulin Clearance in Mice via In Situ Liver Perfusion

Published on: December 13, 2024

232

根据双胆酸清除评估,成年人具有喷泉循环的肝脏 perfusion 的变化

Yuli Y Kim1,2, Annique Nyman2, Yuan-Shung Huang3

  • 1Division of Cardiology Hospital of the University of Pennsylvania Philadelphia PA.

Journal of the American Heart Association
|March 21, 2025
PubMed
概括

在患有Fontan循环 (FC) 的成年人中,胆酸清除受损,这是一种与复杂的先天性心脏病相关的疾病. 更糟糕的Fontan生理学与更高的分流百分比相关,这表明血液动力学问题有助于肝病的进展.

关键词:
这里是Fontan Fontan.丰丹相关的肝病遗传性心脏病是一种先天性心脏病.一个单心室单心室.

更多相关视频

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases06:21

Author Spotlight: Investigating Hepatic Adaptations and Prediabetic Progression in Liver Diseases

Published on: October 6, 2023

1.6K
Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts09:29

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

14.7K

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...